Hypoxia-inducible factor 1 (HIF-1) is a transcription factor functioning in cellular adaptive responses to hypoxia. Recent studies have suggested that HIF-1 activity is upregulated by one of the important circadian clock genes, period circadian clock 2 (PER2); however, its underlying mechanism remains unclear. Here, we show that PER2 functions as an effector protein for the recruitment of HIF-1a to its cognate enhancer sequence, the hypoxia-response element (HRE). We found that the forced expression of PER2 enhanced HIF-1 activity without influencing expression levels of the regulatory subunit of HIF-1, HIF-1a, at either mRNA or protein levels. A series of coimmunoprecipitation-based experiments revealed that PER2 interacted with HIF-1a and facilitated the recruitment of HIF-1a to HRE derived from vascular endothelial growth factor (VEGF) promoter. The PER2-mediated activation of HIF-1 was observed only when the asparagine residue at position 803 of HIF-1a (HIF-1a N803) was kept unhydroxylated by hypoxic stimulation, by introducing an N803A point mutation, or by an inhibitor of N803-dioxygenase, deferoxamine. However, the extent of PER-2-HIF-1a interaction was equivalent regardless of the N803 hydroxylation status. Taken together, these results suggest that, with the help of an unknown sensor molecule for the N803 hydroxylation status, PER2 functions as an effector molecule for the recruitment of HIF-1 to promoter regions of its downstream genes. Our findings reveal a novel regulatory step in the activation of HIF-1, which can be targeted to develop therapeutic strategies against HIF-1-related diseases, such as cancers.
Hypoxia-inducible factor 1 (HIF-1) is a transcription factor functioning in cellular adaptive responses to hypoxia. Recent studies have suggested that HIF-1 activity is upregulated by one of the important circadian clock genes, period circadian clock 2 (PER2); however, its underlying mechanism remains unclear. Here, we show that PER2 functions as an effector protein for the recruitment of HIF-1a to its cognate enhancer sequence, the hypoxia-response element (HRE). We found that the forced expression of PER2 enhanced HIF-1 activity without influencing expression levels of the regulatory subunit of HIF-1, HIF-1a, at either mRNA or protein levels. A series of coimmunoprecipitation-based experiments revealed that PER2 interacted with HIF-1a and facilitated the recruitment of HIF-1a to HRE derived from vascular endothelial growth factor (VEGF) promoter. The PER2-mediated activation of HIF-1 was observed only when the asparagine residue at position 803 of HIF-1a (HIF-1a N803) was kept unhydroxylated by hypoxic stimulation, by introducing an N803A point mutation, or by an inhibitor of N803-dioxygenase, deferoxamine. However, the extent of PER-2-HIF-1a interaction was equivalent regardless of the N803 hydroxylation status. Taken together, these results suggest that, with the help of an unknown sensor molecule for the N803 hydroxylation status, PER2 functions as an effector molecule for the recruitment of HIF-1 to promoter regions of its downstream genes. Our findings reveal a novel regulatory step in the activation of HIF-1, which can be targeted to develop therapeutic strategies against HIF-1-related diseases, such as cancers.
Introduction
Molecular mechanisms underlying the sensing of extracellular oxygen levels and oxygen homeostasis are essential for the survival of cells of the so-called metazoan species [1, 2] . Hypoxia-inducible factor 1 (HIF-1) is recognized as a master transcriptional regulator of them [3, 4] , and dysregulations of its activity have been reported to cause various diseases [1, 2] . For example, aberrant overexpression of the regulatory subunit of HIF-1, HIF-1a, because of biallelic mutations and resultant inactivation of a negative regulator of HIF-1, von-Hippel Lindau protein (pVHL; see below for details), is associated with a hereditary cancer syndrome characterized by an increased risk of clear-cell RCC, VHL disease [5, 6] . In addition, accumulating evidence has demonstrated the involvements of HIF-1 in chemo-/radioresistance [7] [8] [9] [10] , invasion, metastasis [11, 12] , metabolic reprogramming [13] [14] [15] , and both the induction and maintenance of the stemness of cancer cells [16] [17] [18] , etc. To overcome these problems, it is important to fully elucidate the molecular mechanisms behind the regulation of HIF-1 activity.
The HIF-1 is a heterodimeric transcription factor composed of a regulatory subunit, HIF-1a, and a constitutively expressed b-subunit (HIF-1b) [10, [19] [20] [21] [22] . HIF-1 activity is known to be mainly dependent on the stability and transactivation activity of HIF-1a protein.
Proline residues at positions 402 amino acid (a.a.) and 564 a.a. of HIF-1a are hydroxylated by oxygen-dependent dioxygenases, prolyl-4-hydroxylases (PHDs) [23, 24] . The modification triggers the ubiquitination of HIF-1a protein by the pVHL-containing E3 ubiquitin ligase, leading to the proteolysis of HIF-1a through the ubiquitin-proteasome system [24] [25] [26] . Therefore, the deficiency of functional pVHL causes the accumulation of HIF-1a protein in VHL disease-associated cancer syndrome, as mentioned above [5] . Another oxygendependent dioxygenase, factor-inhibiting HIF-1 (FIH-1), also hydroxylates the asparagine residue of HIF-1a at position 803 a.a., which suppresses the recruitment of the transcriptional coactivators, p300/CREB-binding protein (CBP) acetyltransferases, to HIF-1a protein and results in the oxygen-dependent inactivation of its transactivation activity [3, 27] . In contrast, the HIF-1a protein becomes stable and acquires transactivation activity under hypoxic conditions because of the inactivation of these oxygen-dependent dioxygenases [3, 23, 24, 27] . Sequentially speaking, HIF-1a translocates into the nucleus [28] and interacts with its binding partner HIF1b there. The resultant heterodimer, HIF-1, eventually induces the transcription of no less than hundreds of its downstream genes with the help of p300/CBP.
In addition to these oxygen-dependent mechanisms, HIF-1 activity is known to also be regulated through other multiple mechanisms, as follows. Transcription of the HIF-1a gene was reported to be upregulated via the phosphatidylinositol 3 kinase-Akt/protein kinase C/histone deacetylase (PI3K-Akt/PKC/HDAC) pathway, leading to the accumulation and activation of HIF-1a in tumor cells [29] . HER2 signaling was demonstrated to stimulate the neosynthesis (translational initiation) of HIF-1a protein in a PI3K/Akt/mammalian target of rapamycin (mTOR)-dependent manner without affecting the half-life of HIF-1a protein [30] . Although how HIF-1 activity is regulated has been relatively wellcharacterized, as mentioned above, the existence of another mechanism, such as for its translocation to the nucleus or more specifically to promoter regions of its downstream gene, has only been suggested, and its details remain to be elucidated [28, 31, 32] .
The circadian rhythm, a biological process that exhibits an entrainable oscillation of about 24 h, is controlled by a transcription-translation feedback loop composed of positive regulators, CLOCK and BMAL1, and negative ones, PER and cryptochrome (CRY) [33] . The circadian rhythm has received marked attention [34, 35] because it has been reported to be functionally and mechanistically linked with both hypoxia responses and the malignant progression of cancer cells. For example, expressions of representative circadian clock genes, DEC1 and DEC2, are known to be HIF-1 dependent [36] . Moreover, HIF-1 was reported to increase the amplitude of PER2 oscillation through its direct recruitment to the HIF-binding site of the PER2 promoter [37] . Meanwhile, although the influence of PER2 on HIF-1 activity was also reported [38] , the detailed molecular mechanism behind it remains largely unknown.
In the present study, we analyzed the molecular mechanism underlying the PER2-mediated activation of HIF-1, and successfully revealed the existence of a novel regulatory step of HIF-1: PER2 functions as an effector molecule to elicit the recruitment of HIF-1 to its cognate enhancer sequence: the hypoxia-response element (HRE).
Results

PER2 upregulates HIF-1 activity under hypoxic conditions
Consistent with novel upstream activators of HIF-1 that we recently identified, isocitrate dehydrogenase 3 (IDH3), ubiquitin C-terminal hydrolase L1 (UCHL1), and lymphocyte antigen 6 complex, locus E (LY6E) [11, 39, 40] , we noted the possibility that the aberrant overexpression of PER2 elicits HIF-1 activity. To examine the impact of PER2 overexpression on HIF-1 activity, we performed luciferase assays using the p5HRE-Luc plasmid encoding 5HREp-Luc reporter gene, in which five repeats of HRE derived from the human VEGF gene are responsible for the HIF-1-dependent expression of luciferase [41] . The forced expression of PER2 significantly upregulated HIF-1 activity in cervical cancer-derived HeLa cells under hypoxic conditions but not under normoxic conditions (Fig. 1A) . The same results were observed in other kinds of cells, such as colon cancer-derived HCT116 and African green monkey kidney-derived COS-7 cells, suggesting the generality of PER2's function (Fig. 1B,C) .
Identification of a critical regulatory step for the PER2-mediated activation of HIF-1
We performed a series of luciferase assays using sophisticated reporter genes to identify a critical regulatory step for the PER2-mediated upregulation of HIF-1 activity. First, we utilized the HIF-1a promoter-luc reporter gene, pHIF-1a promoter-luc plasmid [40] , to investigate the impact of PER2 overexpression on the transcriptional initiation of the HIF-1a gene. The luciferase assay showed that the bioluminescence intensity was not changed by PER2 overexpression (Fig. 2A) . A quantitative real-time reverse transcriptase PCR (qRT-PCR) experiment demonstrated consistent data, whereby PER2 overexpression exhibited no influence on HIF-1a mRNA levels (Fig. 2B) , collectively suggesting that PER2 has no impact on either transcriptional initiation or mRNA stability of the HIF-1a gene. We next tested whether the forced expression of PER2 positively affects the translational initiation of HIF-1a protein. The luciferase assay using the HIF-1a 5 0 UTRluc reporter gene (pGL3/HIF-1a5ʹUTR-luc plasmid [11, 40] ), in which a pyrimidine tract of HIF-1a 5ʹUTR influenced the translational initiation of the luciferase gene, demonstrated that the forced PER2 overexpression had no effect on the initiation of HIF-1a translation (Fig. 2C) . Then, we examined if PER2 overexpression leads to the stabilization of HIF-1a protein. We employed the SV40p-ODD-Luc reporter gene (pGL3/ODD-Luc plasmid [42] ), which expressed a fusion protein composed of an HIF-1a ODD domain (HIF-1a 548-603 a.a.) and luciferase from the constitutively active SV40 promoter to monitor changes in HIF-1a stability as luciferase bioluminescence. The luciferase assay demonstrated that PER2 overexpression did not enhance the ODD-dependent protein stability (Fig. 2D ). In line with these results, western blotting confirmed that PER2 overexpression did not increase HIF-1a protein levels (Fig. 2E) .
Finally, we performed another luciferase assay to simultaneously evaluate the impact of PER2 overexpression on both the transactivation activity of HIF-1a transactivation domain (TAD) and TAD-mediated recruitment of HIF-1a to promoter regions, as luciferase bioluminescence. We employed a plasmid expressing fusion proteins of the Gal4 DNA-binding domain (Gal4 DBD) and HIF-1a transactivation domain (TAD: 531-826 a.a.; HIF-1a TAD), which are responsible for luciferase expression from the pG5H1bLuc plasmid containing five Gal4-binding sites upstream of an adenovirus E1b promoter and firefly luciferase coding , and COS-7 (C) cells were transiently cotransfected with the 5HRE-Luc reporter gene, pRL/TK as an internal control, and either pcDNA4/PER2 (PER2) or pcDNA4/myc-His A (empty vector: EV), cultured under normoxic or hypoxic conditions, and then subjected to the dual luciferase assay and western blotting using the indicated antibodies. Results are means AE SD; *P < 0.05 Student's t-test (n = 3).
sequence (CDS) [27, 40] . A proline residue in HIF-1a TAD, which corresponded to P564 of HIF-1a, was substituted for alanine to avoid unexpected oxygen-dependent degradation of the fusion protein. The luciferase assay revealed that luciferase bioluminescence was significantly increased by PER2 overexpression under hypoxic but not under normoxic conditions (Fig. 2F ). Taken together, these results indicate that PER2 functions in the upregulation of HIF-1a transactivation activity and/or the recruitment of HIF-1a to its enhancer region and that the so-called TAD of HIF-1a (HIF1a 531-826 a.a.) is sufficient for the regulation.
PER2 upregulates HIF-1 activity when HIF-1a N803 is unhydroxylated
Since our in vitro data in Figs 1 and 2 clearly demonstrated that PER2 was able to enhance HIF-1 activity [30, 40] ), pRL/TK as an internal control, and either pcDNA4/PER2 (PER2) or pcDNA4/myc-His A (EV), HeLa cells were cultured under normoxic or hypoxic conditions, and subjected to the dual luciferase assay and western blotting using the indicated antibodies. (B) After being transiently transfected with either pcDNA4/PER2 (PER2) or pcDNA4/myc-His A (EV), HeLa cells were cultured under normoxic or hypoxic conditions, and subjected to qRT-PCR to quantitate the mRNA levels of HIF-1a and western blotting using the indicated antibodies. (C) After being transiently cotransfected with the HIF-1a-5 0 UTR-luc reporter gene (pGL3/ HIF-1a5ʹUTR-luc plasmid [11, 40] ), pRL/TK as an internal control, and either pcDNA4/PER2-myc-His (PER2) or pcDNA4/myc-His A (EV), HeLa cells were cultured under normoxic or hypoxic conditions, and subjected to the dual luciferase assay and western blotting using the indicated antibodies. (D) After being transiently cotransfected with the SV40p-HIF-1a ODD (548-603 a.a.)-luc reporter gene (pGL3/ODD-Luc plasmid (39)), pRL/TK as an internal control, and either pcDNA4/PER2 (PER2) or pcDNA4/myc-His A (EV), HeLa cells were cultured under normoxic or hypoxic conditions, and then subjected to the dual luciferase assay and western blotting using the indicated antibodies. (E) After being transiently transfected with either pcDNA4/PER2 (PER2) or pcDNA4/myc-His A (EV), HeLa cells were cultured under normoxic or hypoxic conditions, and subjected to western blotting using the indicated antibodies. (F) After being transiently cotransfected with the pG5H1bLuc reporter plasmid, pcDNA6/Gal4 DBD-HIF-1aTAD P564A (531-826 a.a., P564A), pRL/TK as an internal control, and either pcDNA4/PER2 (PER2) or pcDNA4/myc-His A (EV), HeLa cells were cultured under normoxic or hypoxic conditions, and subjected to the dual luciferase assay and western blotting using the indicated antibodies. Results are means AE SD; *P < 0.05 Student's t-test (n = 3).
only under hypoxic conditions, we next assessed the molecular mechanism behind the hypoxia dependency. It has been well-established that FIH-1 hydroxylates the asparagine residue at position 803 of HIF-1a (HIF1a N803) in an oxygen-dependent manner and suppresses the transactivation activity of HIF-1a TAD by inhibiting p300/CBP recruitment to TAD. On the other hand, p300/CBP elicits HIF-1a's transactivation activity under hypoxic conditions because the N803 residue remains unhydroxylated as a result of the hypoxiadependent inactivation of FIH-1 [3, 27] . Therefore, we hypothesized that PER2 would upregulate HIF-1a's transactivation activity in p300/CBP-dependent manners when N803 is unhydroxylated. To assess this, we first examined the influence of the HIF-1a N803 hydroxylation status on PER2-mediated HIF-1 activation. The same kind of luciferase assay as shown in Fig. 2F demonstrated that N803A point mutation, which was resistant to the FIH-1-dependent hydroxylation, significantly enhanced luciferase bioluminescence even under normoxic as well as hypoxic conditions, as we expected (Fig. 3A) . Consistently, when N803 was kept unhydroxylated even under normoxic conditions by treating the cells with an inhibitor of dioxygenases (such as FIH-1), deferoxamine (DFO), the positive impact of PER2 on HIF-1 observed only under hypoxic conditions in Figs 1 and 2F could also be confirmed even under normoxic conditions (Fig. 3B,C) . However, when we analyzed the involvement of p300 using the 5HRE-luc reporter gene, p300 knockdown did not affect the PER2-dependent enhancement of HIF-1 activity (Fig. 3D,E) . These results collectively indicate that PER2 can activate HIF-1 when HIF-1a N803 is unhydroxylated, but it is through a mechanism other than the p300/CBP-mediated upregulation of HIF-1a's transactivation activity.
PER2 interacts with HIF-1a and enhances its recruitment to the enhancer region, HRE
Then, we hypothesized that PER2 would have the potential to interact with HIF-1a when N803 is unhydroxylated under hypoxic conditions, and facilitate the recruitment of HIF-1a to its enhancer region of downstream genes. We performed a coimmunoprecipitation assay using anti-PER2 antibody for immunoprecipitation and anti-HIF-1a antibody for immunoblotting, and obtained surprising data showing that PER2 interacts with HIF-1a regardless of the oxygen conditions (Fig. 4A) . Consistent with this, the interaction between PER2 and HIF-1a proteins was not affected by the introduction of the N803A point mutation into HIF-1a. (Fig. 4B) . These results suggest that PER2 interacts with HIF-1a independently of the N803 hydroxylation status, although the PER2-mediated activation of HIF-1 was influenced by it. We tested whether HIF-1b influences the interaction between HIF-1a and PER2 by performing a coimmunoprecipitation experiment using anti-PER2 antibody for immunoprecipitation and anti-HIF-1a antibody for immunoblotting with or without silencing HIF-1b (Fig. 4C) . The experiment revealed that HIF-1b silencing caused a marked decrease in the HIF-1a-PER2 interaction, indicating that PER2 efficiently recognizes the HIF-1a-HIF-1b heterodimer compared with the HIF-1a monomer, and forms a ternary complex.
In order to examine whether PER2 overexpression increased the efficiency of HIF-1a's recruitment to its target DNA region under hypoxic conditions, we subsequently performed the immunoprecipitation (IP) coupled with quantitative RT-PCR experiments. When the DNA-protein complex was coprecipitated using anti-HIF-1a antibody, PER2 overexpression significantly increased the amount of the precipitated HIF-1 target sequence containing HREs derived from the VEGF gene (Fig. 4D) . Taken together, all of these results suggest that PER2 overexpression elicits HIF-1 activity under hypoxic conditions by facilitating the recruitment of HIF-1a to the enhancer region of its downstream genes.
The N-terminal domain of PER2 is sufficient to facilitate the recruitment of HIF-1a to HRE and upregulate HIF-1 activity Next, we aimed to identify the critical domain of PER2 for PER2-mediated HIF-1 activation. We constructed three kinds of expression vectors for truncated forms of PER2 (Fig. 5A ): PER2-N (N-terminal domain of PER2, PER2 1 -556 a.a., composed of the PAS PAC domain), PER2-M (central domain, PER2 557-771 a.a., composed of the CSNK1E-binding domain), and PER2-C (C-terminal domain, PER2 772-1255 a.a., composed of both the proline-rich domain and CRY-binding domain). The luciferase assay using the 5HREp-Luc reporter gene revealed that only PER2-N enhanced HIF-1 activity (Fig. 5B) . By performing the same kind of luciferase assay as in Fig. 2F using the PER2-N expression vector, we acquired data consistent with Fig. 5B showing that PER2-N was sufficient for the TAD-mediated upregulation of luciferase bioluminescence (Fig. 5C ). Consistent with these data, the N-terminal region of PER2 was confirmed to be sufficient to enhance the recruitment of HIF-1a to its enhancer region, HRE (Fig. 5D) . These results collectively indicate that the PER N-terminal domain is responsible for the recruitment of HIF-1a to HRE and resultant upregulation of HIF-1 activity.
PER2 stimulates HIF-1 activity separately from its binding partner CRY1
CRY1 is characterized as a binding partner of PER2 for the negative regulation of the circadian clock [33] . Thus, we addressed the possibility that PER2 upregulates HIF-1 activity with the help of CRY1 using the reporter gene to monitor HIF-1 activity. The forced expression of CRY1 significantly increased HIF-1 activity without influencing HIF-1a expression levels (Fig. 6) . Interestingly, the increase was further enhanced by the overexpression of PER2 (Fig. 6) . Combined with the result in Fig. 5B that PER2-N, which does not contain the CRY-binding domain (Fig. 5A) , was confirmed to enhance HIF-1 activity, these results suggest that PER2 and CRY1 separately upregulate HIF-1 activity. [27] , either pcDNA6/GAL4 DBD-HIF-1aTAD P564A (HIF-1a-TAD) or pcDNA6/GAL4 DBD-HIF-1aTAD P564a and N803A (HIF1a-TAD N803A), pRL/TK as an internal control, and either pcDNA4/PER2 (PER2) or pcDNA4/myc-His A (EV), HeLa cells were cultured under normoxic or hypoxic conditions, and subjected to the dual luciferase assay and western blotting using the indicated antibodies. (B) After being transiently cotransfected with the 5HRE-luc reporter gene (p5HRE-luc plasmid [41, 47] ), pRL/TK as an internal control, and either pcDNA4/PER2 (PER2) or pcDNA4/myc-His A (EV), HeLa cells were treated with (+) or without (À) deferoxamine (DFO) under normoxic conditions for 24 h, and subjected to the dual luciferase assay. (C) After being transiently cotransfected with the pG5H1bLuc reporter plasmid, pcDNA6 V5 His/GAL4 DBD-HIF-1a-TAD, pRL/TK as an internal control, and either pcDNA4/PER2 (PER2) or pcDNA4/myc-His A (EV), HeLa cells were treated with (+) or without (À) deferoxamine (DFO) for 24 h, and subjected to the dual luciferase assay. (D, E) HeLa cells transiently transfected with p5HRE-Luc, pRL/TK as an internal control, and either pcDNA4/PER2 (PER2) or pcDNA4/myc-His A (EV), were treated with either negative control-siRNA (N. C.) or p300-siRNA (si p300), cultured under hypoxic conditions, and subjected to qRT-PCR to quantify the mRNA levels of p300 (D), the dual luciferase assay, and western blotting using the indicated antibodies (E). Results are means AE SD; *P < 0.05 Student's t-test (n = 3).
Discussion
In the present study, we performed a series of in vitro experiments and analyzed the molecular mechanism underlying the PER2-mediated activation of HIF-1 in detail. We successfully revealed the existence of a novel regulatory mechanism of HIF-1 activity: PER2 functions as an effector molecule for the recruitment of HIF-1 to its enhancer region, HRE.
In the present study, we mainly focused on the impact of PER2 on HIF-1 activity, which is only one aspect of the mechanistic relationship between the circadian rhythm and hypoxia response. On the other hand, Hwang-Verslues et al. and Yu et al. addressed the opposite aspect of the relationship: the impact of hypoxic stimuli on the expression of PER2 [43, 44] . Although we successfully revealed a novel regulatory step of HIF-1, whereby PER2 functions as an effector molecule to elicit the recruitment of HIF-1 to its enhancer, HRE, elucidating both aspects is important to further deepen our understanding of the nature of malignant cancer.
The forced expression of PER2 upregulated HIF-1 activity only when N803 was unhydroxylated not only by hypoxic stimulation but also by N803A point mutation or deferoxamine treatment. Thus, we first postulated the importance of a p300/CBP-dependent increase in the transactivation activity of TAD. However, p300 silencing did not affect the PER2-mediated upregulation of HIF-1 activity. Instead, PER2 was found to enhance the recruitment of HIF-1a to its enhancer region, HRE. This is the most important finding in the present study.
The reason why we applied such a severe oxygen condition (< 0.1%) in the present study was related to the Km value of FIH-1 for O 2 and the influence of the After being transiently cotransfected with the 5HRE-Luc reporter gene (p5HRE-luc plasmid [41, 47] ) and either pcDNA4/PER2 (PER2) or pcDNA4/myc-His A (EV), HeLa cells were cultured under hypoxic conditions, and subjected to the immunoprecipitation experiment with the indicated antibodies. Coprecipitated DNA fragments were subjected to the qRT-PCR experiment using primers against the HIF-1-binding sequence, HRE. Results are means AE SD; *P < 0.05 Student's t-test (n = 12).
hydroxylation status of HIF-1a N803 on the function of PER2. As demonstrated in Fig. 3A , PER2 stimulates the transactivation activity of HIF-1a when the HIF-1a N803 is unhydroxylated. The Km value of FIH-1 for O 2 was reported to be 90 AE 20 lM, which is much lower than that of PHDs [45] . To perform every experiment under the conditions where the N803 was unhydroxylated, we intentionally applied the severe oxygen condition here. The facts that the interaction between HIF-1a and PER2 was not affected by the hydroxylation status of N803 and that PER2 activated HIF-1 only when the N803 was unhydroxylated collectively suggest the existence of an unknown factor, which senses the hydroxylation status of N803 and triggers the PER2-mediated recruitment of HIF-1a. We suggest that the sensor molecule would have the potential to interact with (or at least affect) HIF-1a TAD because we confirmed that domains of HIF-1a other than TAD were not essential for the PER2-mediated activation of HIF-1.
Generally, the luciferase assay system using the expression vector of the GAL4 DBD-HIF-1a TAD (531-826 a.a.) fusion protein and pG5H1bLuc reporter . PER2 stimulates HIF-1 activity separately from its binding partner CRY1. HeLa cells were transiently cotransfected with the 5HRE-Luc reporter gene, pRL/TK as an internal control, and the expression vector for the indicated protein (CRY1 or PER2), cultured under normoxic or hypoxic conditions, and then subjected the dual luciferase assay and western blotting using antibodies for the indicated proteins. Results are means AE SD; *P < 0.05 Student's t-test (n = 3).
plasmid has been exploited to evaluate the transactivating activity of HIF-1a TAD so far [27, 40] . However, our results indicate that the intensity of luciferase bioluminescence from this assay reflects not only the transactivating activity of HIF-1a TAD but also recruitment of the GAL4 DBD-HIF-1a TAD fusion protein to the Gal4-binding sequence.
A previous study reported that PER2 had the potential to increase the levels of both transcripts and protein of HIF-1a [38] . On the other hand, we obtained inconsistent data in the present study. Although the underlying reasons are still not clear, it might be due to the difference in the cellular origin between the two studies: mouse cardiomyocytes and the human cervical carcinoma cell line, HeLa, in the previous and present studies, respectively. Further analysis is needed to fully understand what causes the difference in the mechanistic relationships between PER2 and HIF-1a.
The findings of the present study provide evidence about the existence of a novel PER2-dependent regulatory mechanism for the activation of HIF-1. However, the physiological and pathophysiological importance of the interplay between the circadian clock gene and master regulator of the cellular adaptive response to hypoxia is still unknown. The present study suggests the possibility that PER2 would generate circadian oscillation of the carbohydrate metabolic pathway through its positive impact on HIF-1, because HIF-1 has been reported to negatively regulate mitochondrial functions and trigger the reprogramming of the glucose metabolic pathway from mitochondrial oxidative phosphorylation to glycolysis. Further investigations are critical to answer the remaining questions. Answering these questions will open up new avenues to the development of novel therapeutic strategies against HIF-1-related diseases, such as cancers.
Materials and methods
Cell culture and reagents
The human cervical epithelial adenocarcinoma cell line (HeLa), monkey kidney fibroblast-like cell line (COS-7), and human colon carcinoma cell line (HCT116) were purchased from the American Type Culture Collection (Manassas, VA, USA), and maintained in Dulbecco's modified Eagle medium (DMEM) containing 10% FBS and 100 units penicillin-streptomycin (Nacalai Tesque, Kyoto, Japan). Cells were incubated in a well-humidified 5% CO 2 37°C incubator for normoxic culture. Cells were incubated in the hypoxia work station, INVIVO 2 500 (Ruskinn, York Park, UK) for hypoxic culture (< 0.1% O 2 , 4% H 2 , 5% CO 2 , and 91% N 2 ). The H 2 -containing mix gas was circulated through a palladium catalyst to remove O 2 by forming water. PolyFect Transfection Reagent (Qiagen, Hilden, Germany) were used for transient transfection. Double-stranded RNAs for the transient silencing of HIF1b (cat# HSS100700, cat# HSS100701), and p300 (cat# HSS103258, cat# HSS103259, cat# HSS176564) were purchased from Thermo Fisher Scientific, Inc (Waltham, MA, USA).
Plasmid construction
To construct pcDNA4A/hPER2, the cDNA encoding human PER2 mRNA was obtained from the HeLa cDNA by PCR using the following primers: , pHIF-1a promoterluc [40] , pGL3/HIF-1a5 0 UTR-luc [40] , and pGL3/ODD-Luc
[42] plasmids were constructed as described previously. The pcDNA6/Gal4 DBD-HIF-1aTAD P564A, which expresses a fusion protein of the Gal4 DNA-binding domain (DBD) and HIF-1a TAD (HIF-1a 531-826 a.a.) with the P564A mutation, was constructed as described previously [40] . The N803A mutation was additionally introduced into the pcDNA6/Gal4 DBD-HIF-1aTAD P564A to construct the pcDNA6/Gal4 DBD-HIF-1aTAD P564A and N803A, as described previously [40] . The plasmid pG5H1bLuc, containing five Gal4-binding sites upstream of the adenovirus E1b promoter and firefly luciferase CDS, was described previously [27, 46] . 
Luciferase assay and western blotting
Quantitative real-time PCR (qRT-PCR)
Two days after cells (5 9 10 4 cells/well in a 24-well plate)
had been transfected with the plasmid(s) indicated in each experiment, they were treated under normoxic or hypoxic conditions for 24 h. Total RNA was extracted using Sepasol RNA I Super (Nacalai Tesque) according to the manufacturer's instructions. Total RNA (0.5 lg) was subjected to reverse transcription using the PrimeScript RT reagent Kit (Perfect Real Time) (Takara Bio). The indicated genes' mRNA levels were quantified using the qRT-PCR technique with the Thermal Cycler Dice Real Time System (Takara Bio TP-800), the SYBR Premix Ex-Taq (Tli RNaseH Plus) (Takara Bio), and primers (Takara Primer Set ID HA067803 for human ACTB mRNA, HA074624 for human HIF1A mRNA, HA225874 for human EP300 mRNA, and HA208254 for human CREBBP mRNA) according to the manufacturer's instructions. Human ACTB mRNA levels were used as an internal control for data normalization.
Immunoprecipitation
Two days after cells (1.6 9 10 6 cells/dish in φ100-mm dish)
had been transfected with the plasmids indicated in each experiment, they were treated under normoxic or hypoxic conditions for 24 h, and harvested in 500 lL CelLytic M buffer (Merck Millipore). The lysate was sonicated with Bioruptor (Cosmo Bio UCW-201) for 5 min (30 s ON-30 s OFF; five cycles in total) and centrifuged at 16 100 g. The resultant supernatants were subjected to immunoprecipitation using either the anti-PER2 antibody (Abcam) or the anti-HIF-1a antibody (Abcam Cat # ab1), and Dynabeads Protein G Immunoprecipitation Kit (ThermoFisher) according to the manufacturer's instructions. The immune complexes were subjected to western blotting using the antibodies indicated in each experiment.
IP-qRT-PCR Assay
had been transfected with the plasmids indicated in each experiment, they were treated under normoxic or hypoxic conditions for 24 h, treated with 1% paraformaldehyde in PBS (À) at room temperature for 10 min for crosslinkage between DNA and protein, added with glycine for quenching (final conc. = 136 mM), washed with PBS (À), and then harvested with 1 mL/φ100-mm dish of SDS Lysis buffer (50 mM Tris-HCl pH 8.0, 1% SDS, and 10 mM EDTA). The resultant lysates were sonicated with Bioruptor (Cosmo Bio UCW-201) for 24 min (30 s ON-30 s OFF; 24 cycles in total). After sonication, lysates were centrifuged at 16 100 g, and the resultant supernatants were diluted with IP dilution buffer (16.7 mM Tris-HCl pH 8.0, 1.2 mM EDTA, 167 mM NaCl, 1.1% Triton X-100, and 0.01% SDS). IP was performed using either anti-HIF-1a (Abcam) or its isotype control (BD Bioscience Cat# 554121) antibody and Dynabeads Protein G Immunoprecipitation Kit (ThermoFisher). Precipitates were sequentially washed twice using each of the following buffers: Low salt buffer (20 mM Tris-HCl pH 8.0, 2 mM EDTA, 150 mM NaCl, 1% Triton X-100, and 0.1% SDS), High salt buffer (20 mM Tris-HCl pH 8.0, 2 mM EDTA, 500 mM NaCl, 1% Triton X-100, and 0.1% SDS), LiCl wash buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA, 0.25 M LiCl, 1% IGEPAL-CA630, and 1% sodium deoxycholate), and TE buffer. In order to purify DNA, samples were first incubated in the 100-times-diluted TE buffer at 65°C overnight for the decrosslinking reaction, and DNA was extracted with the QIAquick PCR purification kit (Qiagen). The precipitated DNA levels were quantified using the qRT-PCR technique, as described above, using the following primers: forward: 5 0 -TCTGGTAGGCGTGTACG GTG-3 0 , reverse: 5 0 -GCGCCGGGCCTTTCTTTATG-3 0 .
